Juan Carlos Turriate Gastulo

Array ( [id] => 7314199 [patent_doc_number] => 20040033959 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-19 [patent_title] => 'Pharmaceutical compositions for hepatitis C viral protease inhibitors' [patent_app_type] => new [patent_app_number] => 10/620408 [patent_app_country] => US [patent_app_date] => 2003-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13882 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 600 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20040033959.pdf [firstpage_image] =>[orig_patent_app_number] => 10620408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7409419 [patent_doc_number] => 20040176270 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-09 [patent_title] => 'Use of isocyanate linkers to make hydrolyzable active agent biopolymer conjugates' [patent_app_type] => new [patent_app_number] => 10/618405 [patent_app_country] => US [patent_app_date] => 2003-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 22502 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20040176270.pdf [firstpage_image] =>[orig_patent_app_number] => 10618405 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7382360 [patent_doc_number] => 20040029181 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-12 [patent_title] => 'Novel metal complex and method for determining amino acid sequence of protein using the same' [patent_app_type] => new [patent_app_number] => 10/614324 [patent_app_country] => US [patent_app_date] => 2003-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4661 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20040029181.pdf [firstpage_image] =>[orig_patent_app_number] => 10614324 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7305890 [patent_doc_number] => 20040116346 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Affinity small molecules for the EPO receptor' [patent_app_type] => new [patent_app_number] => 10/612885 [patent_app_country] => US [patent_app_date] => 2003-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 17480 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20040116346.pdf [firstpage_image] =>[orig_patent_app_number] => 10612885 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 732932 [patent_doc_number] => 07037902 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-02 [patent_title] => 'Affinity small molecules for the EPO receptor' [patent_app_type] => utility [patent_app_number] => 10/613754 [patent_app_country] => US [patent_app_date] => 2003-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 17317 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 154 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/037/07037902.pdf [firstpage_image] =>[orig_patent_app_number] => 10613754 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7281239 [patent_doc_number] => 20040063616 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-01 [patent_title] => 'Compositions containing peptide copper complexes and soft tissue fillers, and methods related thereto' [patent_app_type] => new [patent_app_number] => 10/607575 [patent_app_country] => US [patent_app_date] => 2003-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4889 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20040063616.pdf [firstpage_image] =>[orig_patent_app_number] => 10607575 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 800393 [patent_doc_number] => 07425537 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-09-16 [patent_title] => 'SH2 domain binding inhibitors' [patent_app_type] => utility [patent_app_number] => 10/517717 [patent_app_country] => US [patent_app_date] => 2003-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 38 [patent_no_of_words] => 29200 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/425/07425537.pdf [firstpage_image] =>[orig_patent_app_number] => 10517717 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7168768 [patent_doc_number] => 20040077540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-22 [patent_title] => 'Compositions and methods for modulating physiology of epithelial junctional adhesion molecules for enhanced mucosal delivery of therapeutic compounds' [patent_app_type] => new [patent_app_number] => 10/601953 [patent_app_country] => US [patent_app_date] => 2003-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 76249 [patent_no_of_claims] => 92 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20040077540.pdf [firstpage_image] =>[orig_patent_app_number] => 10601953 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7397062 [patent_doc_number] => 20040038867 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-26 [patent_title] => 'Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus' [patent_app_type] => new [patent_app_number] => 10/461199 [patent_app_country] => US [patent_app_date] => 2003-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 20440 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20040038867.pdf [firstpage_image] =>[orig_patent_app_number] => 10461199 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7386395 [patent_doc_number] => 20040029787 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-12 [patent_title] => 'Use of substances with oxytocin activity against climacteric disorders' [patent_app_type] => new [patent_app_number] => 10/258013 [patent_app_country] => US [patent_app_date] => 2003-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7063 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20040029787.pdf [firstpage_image] =>[orig_patent_app_number] => 10258013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7385754 [patent_doc_number] => 20040082509 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-29 [patent_title] => 'Cell-permeable peptide inhibitors of the JNK signal transduction pathway' [patent_app_type] => new [patent_app_number] => 10/457614 [patent_app_country] => US [patent_app_date] => 2003-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 20912 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20040082509.pdf [firstpage_image] =>[orig_patent_app_number] => 10457614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7469516 [patent_doc_number] => 20040054130 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-18 [patent_title] => 'Insulin potentiating peptides' [patent_app_type] => new [patent_app_number] => 10/240578 [patent_app_country] => US [patent_app_date] => 2003-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8205 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20040054130.pdf [firstpage_image] =>[orig_patent_app_number] => 10240578 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5801326 [patent_doc_number] => 20060035839 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-16 [patent_title] => 'Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments' [patent_app_type] => utility [patent_app_number] => 10/516083 [patent_app_country] => US [patent_app_date] => 2003-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13424 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20060035839.pdf [firstpage_image] =>[orig_patent_app_number] => 10516083 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7280775 [patent_doc_number] => 20040063152 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-01 [patent_title] => 'Method for electrochemical analysis, corresponding configurations and the use thereof' [patent_app_type] => new [patent_app_number] => 10/432781 [patent_app_country] => US [patent_app_date] => 2003-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3509 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20040063152.pdf [firstpage_image] =>[orig_patent_app_number] => 10432781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7046088 [patent_doc_number] => 20050250683 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2005-11-10 [patent_title] => 'Reversible modification of membrane interaction' [patent_app_type] => utility [patent_app_number] => 10/444662 [patent_app_country] => US [patent_app_date] => 2003-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9683 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0250/20050250683.pdf [firstpage_image] =>[orig_patent_app_number] => 10444662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7046088 [patent_doc_number] => 20050250683 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2005-11-10 [patent_title] => 'Reversible modification of membrane interaction' [patent_app_type] => utility [patent_app_number] => 10/444662 [patent_app_country] => US [patent_app_date] => 2003-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9683 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0250/20050250683.pdf [firstpage_image] =>[orig_patent_app_number] => 10444662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7409749 [patent_doc_number] => 20040176301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-09 [patent_title] => 'p21 peptides' [patent_app_type] => new [patent_app_number] => 10/441952 [patent_app_country] => US [patent_app_date] => 2003-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 43864 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20040176301.pdf [firstpage_image] =>[orig_patent_app_number] => 10441952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7428767 [patent_doc_number] => 20040230033 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'Substrate-derived affinity labels, and uses thereof' [patent_app_type] => new [patent_app_number] => 10/437376 [patent_app_country] => US [patent_app_date] => 2003-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7186 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0230/20040230033.pdf [firstpage_image] =>[orig_patent_app_number] => 10437376 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7314197 [patent_doc_number] => 20040033957 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-19 [patent_title] => 'FAP-activated anti-tumor prodrugs' [patent_app_type] => new [patent_app_number] => 10/430056 [patent_app_country] => US [patent_app_date] => 2003-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8545 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20040033957.pdf [firstpage_image] =>[orig_patent_app_number] => 10430056 [rel_patent_id] =>[rel_patent_doc_number] =>)